LENSAR, Inc. (LNSR) stock
LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3022% below fair value
$4.85−0.06 (-1.22%)
Close on Nov 18, 2026Market cap $59.59MP/E –Yield –
Lensar cash
Cash and short-term investments held at the end of each period.
Lensar's cash was $13.57M at Jun 30, 2026. For fiscal 2025 it was $17.98M, down 19.9% from the year before. The highest annual figure on record is $40.60M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.98M | -19.9% |
| FY2024 | Dec 31, 2024 | $22.46M | -6.7% |
| FY2023 | Dec 31, 2023 | $24.06M | +64.0% |
| FY2022 | Dec 31, 2022 | $14.67M | -53.6% |
| FY2021 | Dec 31, 2021 | $31.64M | -22.1% |
| FY2020 | Dec 31, 2020 | $40.60M | +779.7% |
| FY2019 | Dec 31, 2019 | $4.62M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $13.57M | -33.2% |
| Q1 FY2026 | Mar 31, 2026 | $13.50M | -46.5% |
| Q4 FY2025 | Dec 31, 2025 | $17.98M | -19.9% |
| Q3 FY2025 | Sep 30, 2025 | $16.87M | -6.7% |
| Q2 FY2025 | Jun 30, 2025 | $20.31M | +42.9% |
| Q1 FY2025 | Mar 31, 2025 | $25.25M | +41.0% |
| Q4 FY2024 | Dec 31, 2024 | $22.46M | -6.7% |
| Q3 FY2024 | Sep 30, 2024 | $18.08M | -27.4% |
| Q2 FY2024 | Jun 30, 2024 | $14.21M | -44.2% |
| Q1 FY2024 | Mar 31, 2024 | $17.91M | +124.7% |
| Q4 FY2023 | Dec 31, 2023 | $24.06M | +64.0% |
| Q3 FY2023 | Sep 30, 2023 | $24.92M | +29.2% |
| Q2 FY2023 | Jun 30, 2023 | $25.47M | +1.1% |
| Q1 FY2023 | Mar 31, 2023 | $7.97M | -72.5% |
| Q4 FY2022 | Dec 31, 2022 | $14.67M | -53.6% |
| Q3 FY2022 | Sep 30, 2022 | $19.29M | -40.3% |
| Q2 FY2022 | Jun 30, 2022 | $25.20M | -27.1% |
| Q1 FY2022 | Mar 31, 2022 | $28.98M | -19.2% |
| Q4 FY2021 | Dec 31, 2021 | $31.64M | -22.1% |
| Q3 FY2021 | Sep 30, 2021 | $32.34M | -24.3% |
| Q2 FY2021 | Jun 30, 2021 | $34.55M | +648.7% |
| Q1 FY2021 | Mar 31, 2021 | $35.87M | – |
| Q4 FY2020 | Dec 31, 2020 | $40.60M | – |
| Q3 FY2020 | Sep 30, 2020 | $42.70M | – |
| Q4 FY2019 | Dec 31, 2019 | $4.62M | – |
See a number that looks wrong?